A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions Among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Human papillomavirus vaccine recombinant nonavalent Merck (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Acronyms COVENANT
- 09 Jan 2018 Planned initiation date changed from 1 May 2018 to 1 Jun 2018.
- 09 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 May 2018.
- 15 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.